Health Care & Life Sciences » Biotechnology | Human Metabolome Technologies Inc.

Human Metabolome Technologies Inc. | Income Statement

Fiscal year is April-March. All values JPY Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
610,356.00
686,618.00
780,377.00
914,180.00
938,178.00
834,125
Cost of Goods Sold (COGS) incl. D&A
198,379.00
220,491.00
209,704.00
185,079.00
195,724.00
256,032
Gross Income
411,977.00
466,127.00
570,673.00
729,101.00
742,454.00
578,093
SG&A Expense
424,318.00
566,639.00
641,030.00
772,433.00
883,368.00
943,360
EBIT
12,341.00
100,512.00
70,357.00
43,332.00
140,914.00
365,267
Unusual Expense
-
4,335.00
-
-
-
1,400
Non Operating Income/Expense
21,208.00
83,855.00
3,881.00
2,393.00
8,595.00
10,944
Interest Expense
2,999.00
1,754.00
1,075.00
377.00
572.00
593
Pretax Income
5,962.00
21,895.00
73,423.00
40,410.00
149,173.00
356,080
Income Tax
4,335.00
12,833.00
1,954.00
21,503.00
7,354.00
3,906
Consolidated Net Income
1,627.00
34,728.00
71,469.00
61,913.00
156,527.00
359,986
Net Income
1,627.00
34,728.00
71,469.00
61,913.00
156,527.00
359,986
Net Income After Extraordinaries
1,627.00
34,728.00
71,469.00
61,913.00
156,527.00
359,986
Net Income Available to Common
1,627.00
34,728.00
71,469.00
61,913.00
156,527.00
359,986
EPS (Basic)
0.38
6.59
13.41
10.86
26.92
61.57
Basic Shares Outstanding
4,203.30
5,272.30
5,330.90
5,701.60
5,815.10
5,847.10
EPS (Diluted)
0.35
6.59
13.41
10.86
26.92
61.57
Diluted Shares Outstanding
4,712.10
5,272.30
5,330.90
5,701.60
5,815.10
5,847.10
EBITDA
24,160.00
29,364.00
8,895.00
9,913.00
79,444.00
301,584
Non-Operating Interest Income
94.00
851.00
1,890.00
906.00
909.00
235

About Human Metabolome Technologies

View Profile
Address
246-2 Mizukami, Kakuganji
Tsuruoka Yamagata 997
Japan
Employees -
Website http://humanmetabolome.com
Updated 07/08/2019
Human Metabolome Technologies, Inc. engages in diagnostic technology and medical products. Its operations are carried out through the following segments: Metabolome Analysis, Biomarker, and Temporary Staffing. The Metabolome Analysis segment provides contract analysis service based on the metabolome analysis on measured samples from the clients.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.